Great news6 Nov 2017 07:42
After the nightmare of being delisted and risking being take down altogether, I am very happy with today's release. It says exactly what most understandably disgruntled investors wanted to hear:
Positive BoD changes, a more focused pipeline, a strengthened balance sheet, reduced costs, and so on. Obviously losing BTK is a negative, but now I am hopeful that the company will be much better managed than before, because they have had one heck of a wake up call and this is a rare second chance.
Onward and upwards. Will see how the SP reacts today and average down accordingly, with hope that the 'milestones' mentioned today will be met as the company moves along their 'cash runway'. Very few pharma on AIM have such a runway and we should ideally be in phase 2 trials with the lead candidate by then, while other positive news may happen in the meantime.
Whether I'm right or wrong, at least it's a second chance! Anyone else here planning to increase their holding on a dip this week?
GLA.